BIAGINI, AGNESE
 Distribuzione geografica
Continente #
EU - Europa 1.059
NA - Nord America 1.007
AS - Asia 192
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.309
Nazione #
US - Stati Uniti d'America 982
DE - Germania 583
SE - Svezia 163
CN - Cina 115
GB - Regno Unito 96
IT - Italia 73
BG - Bulgaria 57
CI - Costa d'Avorio 35
CA - Canada 25
AT - Austria 24
IN - India 21
RU - Federazione Russa 19
SG - Singapore 19
FI - Finlandia 16
SN - Senegal 15
VN - Vietnam 15
TR - Turchia 11
BE - Belgio 10
NL - Olanda 5
UA - Ucraina 5
FR - Francia 3
HK - Hong Kong 3
AZ - Azerbaigian 2
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.309
Città #
Chandler 108
Woodbridge 100
Fairfield 97
Ann Arbor 92
Ashburn 80
Sofia 57
Beijing 50
New York 41
Wilmington 40
Houston 39
Abidjan 35
Seattle 35
Cambridge 34
Princeton 25
Boulder 23
Ottawa 23
Vienna 22
Bremen 21
Des Moines 20
Lawrence 20
London 18
Medford 18
Dearborn 17
Dakar 15
Florence 15
Serra 13
Los Angeles 11
Nanjing 11
Nürnberg 11
Brussels 10
Izmir 10
Changsha 8
Frankfurt am Main 8
Dong Ket 6
Jiaxing 6
Lancaster 6
Munich 6
Nanchang 4
Pisa 4
San Diego 4
Bengaluru 3
Chengdu 3
Düsseldorf 3
Hangzhou 3
Jacksonville 3
Ningbo 3
Palermo 3
Pune 3
Shanghai 3
Washington 3
Wuhan 3
Baotou 2
Buffalo 2
Guangzhou 2
Hong Kong 2
Kunming 2
Nutley 2
Ogden 2
Redmond 2
Redwood City 2
Sacile 2
Schiphol 2
Siena 2
Tappahannock 2
Tianjin 2
Auburn Hills 1
Boardman 1
Bratislava 1
Chelmsford 1
Chicago 1
Copenhagen 1
Council Bluffs 1
Crawley 1
Delhi 1
Fuzhou 1
Grafing 1
Groningen 1
Hebei 1
Hefei 1
Hejin 1
Indiana 1
Istanbul 1
Jinan 1
Lanzhou 1
Manila 1
Maruthayur 1
Naples 1
Norwalk 1
Pantai 1
Quzhou 1
Rochester 1
San Francisco 1
San Jose 1
San Ramon 1
Shenyang 1
Simi Valley 1
Singapore 1
Stafford 1
Tel Aviv 1
Toronto 1
Totale 1.259
Nome #
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 258
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 155
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE 146
null 145
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 140
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 139
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 132
Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico. 122
Il carcinoma tiroideo: nuove prospettive terapeutiche. 119
null 107
null 105
null 84
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) 80
Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience 79
Significato prognostico della mutazione di BRAF in pazienti affetti da carcinoma papillare della tiroide con follow-up di 20 anni. 77
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 76
Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor. 68
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) 68
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. 64
. Utilità della ricerca della mutazione di BRAF nel tumore primitivo di pazienti affetti da carcinoma papillare della tiroide a basso rischio. 41
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study 37
Il carcinoma della tiroide 33
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. 29
Ret Oncogene and Thyroid Carcinoma 20
How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level. 17
Totale 2.341
Categoria #
all - tutte 5.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019122 0 0 0 0 0 0 0 0 0 0 67 55
2019/2020557 75 51 52 27 43 59 52 26 31 57 78 6
2020/2021114 19 8 19 1 4 3 13 9 6 9 4 19
2021/2022266 10 10 2 26 59 33 11 7 13 9 13 73
2022/2023440 59 77 38 35 34 42 8 29 82 1 31 4
2023/2024145 16 11 15 0 21 46 18 6 3 9 0 0
Totale 2.341